Concepedia

Publication | Open Access

Second-Line Capecitabine and Oxaliplatin Combination for Gemcitabine-Resistant Advanced Pancreatic Cancer

DOIFull Paper Access

16

Citations

27

References

2014

Year

İbrahim Vedat Bayoğlu, Umut Varol, Ugur Muslu, Ahmet Alacacıoğlu, Yüksel Küçükzeybek, Murat Akyol, Lütfiye Demir, Ahmet Dirican, Suna Çokmert, Bülent Karabulut,
Asian Pacific Journal of Cancer Prevention

Abstract

Our result suggests that the combination of capecitabine and oxaliplatin was tolerated with manageable toxicity and showed encouraging activity as second-line treatment of advanced or metastatic pancreatic cancer patients with ECOG performance status 0-2.

References

YearCitations

Page 1